Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues

Immunity
C A ScottI A Wilson

Abstract

We have determined the structures of I-Ad covalently linked to an ovalbumin peptide (OVA323-339) and to an influenza virus hemagglutinin peptide (HA126-138). The floor of the peptide-binding groove contains an unusual beta bulge, not seen in I-E and DR structures, that affects numerous interactions between the alpha and beta chains and bound peptide. Unlike other MHC-peptide complexes, the peptides do not insert any large anchor residues into the binding pockets of the shallow I-Ad binding groove. The previously identified six-residue "core" binding motif of I-Ad occupies only the P4 to P9 pockets, implying that specificity of T cell receptor recognition of I-Ad-peptide complexes can be accomplished by peptides that only partially fill the MHC groove.

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
May 20, 1991·Journal of Molecular Biology·M A SaperD C Wiley
May 1, 1989·The Journal of Experimental Medicine·J M BuersteddeD J McKean
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A SetteH M Grey
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·A M GautamP J Milburn
Jan 1, 1995·Immunogenetics·H G RammenseeS Stevanoviíc
Jan 1, 1994·Annual Review of Immunology·P Cresswell
Feb 22, 1994·Biochemistry·S N Witt, H M McConnell
Dec 1, 1993·Current Opinion in Immunology·R D Campbell, C M Milner
Sep 1, 1993·Protein Science : a Publication of the Protein Society·C Colovos, T O Yeates
Jan 1, 1996·The Journal of Experimental Medicine·H A RunnelsP E Jensen
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·T S JardetzkyD C Wiley
May 3, 1996·Cell·R Tisch, H McDevitt
May 17, 1996·Science·I A Wilson
Nov 29, 1996·Cell·V KouskoffD Mathis
Apr 1, 1998·Protein Science : a Publication of the Protein Society·C A ScottL Teyton

❮ Previous
Next ❯

Citations

Oct 3, 1999·European Journal of Immunology·P W BryantA J Sant
Feb 22, 2002·Medicinal Research Reviews·Benjamin J McFarland, Craig Beeson
Jul 20, 2001·Journal of Peptide Science : an Official Publication of the European Peptide Society·S HenriotE Trifilieff
Mar 17, 2004·Immunology Letters·Shigeru SugiyamaNobumichi Hozumi
Mar 24, 2004·Molecular Immunology·Alexander J BankovichK Christopher Garcia
Dec 31, 2002·Immunology Letters·Toranosuke TobitaHaruo Kozono
Feb 3, 2000·Immunology Letters·K BartnesK Hannestad
May 4, 2001·Human Immunology·P KangueaneE C Ren
Dec 23, 1999·Current Opinion in Structural Biology·K Maenaka, E Y Jones
Jun 5, 2003·International Immunopharmacology·Kiyoshi Takatsu, Ai Kariyone
Sep 8, 2012·Nature Reviews. Immunology·James F Mohan, Emil R Unanue
Oct 31, 2002·Immunology and Cell Biology·Vijaya NagabhushanamChristina Cheers
Oct 23, 1998·The Journal of Experimental Medicine·K J SmithK W Wucherpfennig
Apr 17, 2002·The Journal of Experimental Medicine·Daved H FremontJohn Kappler
Nov 9, 2011·The Journal of Experimental Medicine·James F MohanEmil R Unanue
Sep 15, 2007·International Immunology·Amy GardinerLynne S Arneson
Jan 13, 2000·Immunological Reviews·R R Latek, E R Unanue
Jun 24, 2004·Infection and Immunity·Kristina M Williams, Elmer C Bigley
Jun 8, 1999·Annual Review of Immunology·K C GarciaI A Wilson
Aug 2, 2002·American Journal of Respiratory Cell and Molecular Biology·Edith M JanssenAntoon J M van Oosterhout
Feb 13, 2013·BMC Bioinformatics·Cem MeydanOsman Uğur Sezerman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.